Due: February 15, 2024
This RPP is focused on the development of a software prototype that will allow a medical planner to assess the residual operational risk for a mission after layering in threat risk, medical countermeasure (MCM) risk-benefit tradeoffs, and fielding risk during mission planning. The AMDST layering model is intended to include all MCMs for a potential threat, including FDA-approved, repurposed, and investigational drugs. One of the goals for AMDST is to make operational planners aware of MCMs in the investigational and repurposed drug pipeline, allowing a demand signal from operations for MCM interim fielding.
This opportunity requires membership in the MTEC Consortium. This Consortium releases numerous opportunities throughout the year, so even if this one may not be right for you, we strongly encourage you to join the consortium, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.